Evidence Before Action.
DOSSIRI is the compliance-aware Account Intelligence Platform for life sciences and regulated-industry sales teams. It brings your account history, Evidence, regulatory signals, and market intelligence into one clear brief — before every conversation.
FDA Form 483 issued to Alderpoint's primary contract manufacturer, March 2026.
Source: FDA inspection database
Series C raise in Q1 2026, earmarked in part for expanded lab capacity.
Source: company press release
Prior conversation flagged a Q3 evaluation window tied to a board decision.
Source: account notes, added by rep
The account story lives in six places. None of them talk to each other.
Critical account context is scattered across your CRM, email, regulatory databases, market news, and the memory of whoever worked the account last. Preparing for one important meeting can mean hours of manual digging — and you can still walk in missing the one detail that would have changed the conversation.
- Regulatory and organizational changes that are easy to miss
- Context that disappears when a rep changes territory or leaves
- Activity logs that record what happened but not the evidence behind what to do next
- Hours spent assembling a story that should already exist
One workspace. Everything you need to know.
Account Intelligence
Every account and prospect has a workspace. As deals progress and signals surface, DOSSIRI synthesizes what matters — so over time, each account becomes more intelligent, not just more documented.
Signal Monitoring
DOSSIRI monitors regulatory activity, clinical trial postings, and company signals across both your active accounts and the prospects you're working to win. When something changes that matters, it surfaces in your workspace.
Pre-Call Preparation
When you're ready to engage, request a pre-call brief. DOSSIRI draws on your private account context, accumulated signals, and current regulatory intelligence — so every conversation starts with evidence, not assumptions.
Built for regulated industry. Not adapted for it.
The intelligence builds as you work.
DOSSIRI turns each account into a living memory. The context you add, the signals it monitors, and the evidence it connects stay organized by account instead of disappearing into disconnected records and searches.
The more evidence accumulates, the more useful each account becomes.
NCT05982134 posted Phase III results on June 2. Primary endpoint met. Likely to accelerate outsourcing decisions in Q3 manufacturing pipeline.
Monitored by DOSSIRI · June 3, 2026
Self-reported 21 CFR Part 11 compliance on website — not independently verified. Raised in April call. Team did not confirm.
Flagged by DOSSIRI · April 2026
VP of Quality confirmed evaluation window opens Q3. Board meeting in August is the decision gate.
Added by you · May 2026
Assessment based on evidence
Assessments, not guesses.
DOSSIRI doesn't reduce an opportunity to a single number. That kind of certainty can hide uncertainty. Instead, it gives you a structured assessment of the opportunity — what the evidence supports, what's uncertain, and what needs to be answered.
Human judgment stays in the seat.
Three workflows. One workspace.
Build Your Account Workspace
Add accounts, contacts, deals, and evidence. DOSSIRI starts accumulating. CRM Core remains useful without Intelligence features, so your account records, Evidence, Account History, and workflows remain structured and available.
Intelligence Accumulates
Signal monitoring surfaces what changed across your accounts and prospects. ICP analysis assesses fit. Compliance context, regulatory activity, and company signals accumulate in the background — organized by account, ready when you need them.
Walk Into Every Meeting Prepared
When you're ready to engage, request a pre-call brief. DOSSIRI draws on your private context and gathers current intelligence — so every conversation starts with evidence, not assumptions.
Here's what a pre-call brief actually looks like.
Built on a fictional account, so you can see the shape of a DOSSIRI brief before you ever sign up — the structure, the sourcing, the evidence trail.
Mid-size diagnostics manufacturer evaluating outsourced lab capacity ahead of a Q3 board decision. Primary contact: VP of Quality.
FDA Form 483 issued to Alderpoint's primary contract manufacturer, March 2026 — no product recalls to date.
Source: FDA inspection database, March 2026
Alderpoint announced a Series C raise in Q1 2026, earmarked in part for expanded lab capacity.
Source: company press release, February 2026
Prior conversation flagged a Q3 evaluation window tied to a board decision on outsourcing lab work.
Source: account notes, added by rep, January 2026
- Reference the Series C raise as context for expanded lab-capacity needs.
- Ask directly whether the Form 483 finding is resolved and whether it affects the evaluation timeline.
- Confirm whether the Q3 board decision changes the buying window.
Illustrative example built on a fictional account and fictional data. Not a screenshot of the DOSSIRI application.
Know what matters. Before every conversation.
Life sciences sales requires precision. A misread compliance claim or a missed regulatory development can cost you a deal.
DOSSIRI is built around a single principle: every output is grounded in evidence, and you always know what DOSSIRI knows — and what it doesn't.
Sources Referenced
Every brief cites where the intelligence came from. No black boxes.
Confidence Indicated
DOSSIRI distinguishes between strong evidence and informed inference.
What You Know, First
Insider context you add takes priority. DOSSIRI builds around it, not over it.
Built by someone who lived the problem.
DOSSIRI is built by a life sciences sales professional with 15 years selling into regulated markets — where a missed detail can change a customer conversation, and the full account story rarely lives in one place. Existing CRMs recorded activity. They didn't assemble the evidence a seller actually needed to decide what to do next.
If you sell into regulated environments, DOSSIRI was built for you.
CRO Sales
Contract research organizations
CDMO Sales
Contract development & manufacturing
Medical Device
FDA-regulated device manufacturers & distributors
GxP Technology
Validated software & systems
Regulatory Technology
Regulatory affairs & submission tools
Clinical Technology
EDC, CTMS, clinical operations
Quality & Compliance
QMS, audit, and inspection readiness
Lab Equipment
Analytical instruments & lab systems
Bioanalytical Services
Bioanalytical labs & CRO support services
Pharmaceutical Sales
Pharmaceutical manufacturers & commercial teams
Any commercial role where compliance context, regulatory knowledge, or domain specificity determines whether you win.
Your data. Your evidence. Always traceable.
Read our Privacy Policy and Terms of Service.
Less time assembling the story. More time acting on it.
- Spend less time researching accounts before a call.
- Preserve institutional knowledge when territories or reps change.
- Catch the regulatory or market development that changes the next conversation, before a competitor does.
- Walk in with evidence, not a guess.
Know what matters before every conversation.
Start your free trial and help shape the future of evidence-backed account intelligence for regulated industries.
Start Free Trial →14-day free trial. Your payment method is collected securely at signup. You won't be charged unless you continue after your trial ends. Cancel anytime during your trial.